carbonthatcarbonthat
← Every company

Ono Pharmaceutical Co Ltd Patents

What Ono Pharmaceutical Co Ltd has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.

OPHLY on carbonthat →
Filings on file
20
Granted
1
Still pending
19
Filed under
1 names

20 filings

Newest filing first. A pending application has no patent number yet, and most never get one.

InventionPatent
SUBSTITUTED CYCLOPENTA[c]PYRROLES AS ABHD6 ANTAGONISTSA61K 31/136, C07D 409/14, C07D 495/14, A61P 37/00, A61P 43/00, A61P 3/00, A61P 9/06, A61P 25/04, A61P 21/02, A61P 25/24, A61P 25/00, A61P 25/08, A61P 29/00, A61P 19/10, A61P 25/06, A61P 35/00, A61K 9/20, A61K 31/4439, A61K 31/501, A61K 45/00, A61K 45/06, C07D 403/12, C07D 405/14, C07D 417/14, C07D 487/04, C07D 495/04, C07D 513/04Filed as ONO PHARMACEUTICAL CO., LTD.2026-03-09Atsushi Yoshidapending
INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTIONFiled as ONO PHARMACEUTICAL CO., LTD.2025-12-16CRAIG W. LINDSLEYpending
HUMAN-DERIVED ANTI-COLLAPSIN RESPONSE MEDIATOR PROTEIN 2 (CRMP2) ANTIBODIESC07K 16/18, A61P 25/28, A61K2039/505, C07K2317/33, C07K2317/92Filed as ONO PHARMACEUTICAL CO., LTD.2025-10-23Katsukuni MITSUIpending
THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING FP AGONIST AND ß BLOCKERA61K 9/0048, A61K 31/335, A61P 27/02, A61P 27/06, A61K 9/06, A61K 9/08, A61K 31/138, A61K 31/343, A61K 31/353, A61K 31/4704, A61K 31/5377, A61K 47/02, A61K 47/12, A61K 47/26, A61K2300/00, C07D 313/06Filed as ONO PHARMACEUTICAL CO., LTD.2025-09-03Shinsaku YAMANEpending
GBA1 AND GCS DUAL MODULATORC07D 223/08, C07D 417/12, A61P 25/28, A61P 43/00, A61P 3/00, A61P 3/10, A61P 25/00, A61P 35/00, A61K 31/55, A61K 45/06, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12Filed as ONO PHARMACEUTICAL CO., LTD.2025-08-25Takashi KONDOpending
BISPECIFIC ANTIBODYA61P 1/00, A61K 39/395, C07K 16/2803, C07K 16/2818, A61P 7/06, A61P 37/00, A61P 21/00, A61P 37/02, A61P 1/16, A61P 9/00, A61P 11/06, A61P 17/14, A61P 37/06, A61P 17/00, A61P 19/02, A61P 37/08, A61P 3/10, A61P 5/00, A61P 15/00, A61P 25/00, A61P 29/00, A61P 11/02, A61K 45/00, A61K 45/06, A61K2039/505, C07K 16/28, C07K 16/46, C07K2317/21, C07K2317/31, C07K2317/33, C07K2317/526, C07K2317/55, C07K2317/567, C07K2317/76, C07K2317/92, C07K2317/94Filed as ONO PHARMACEUTICAL CO., LTD.2025-05-05Shiro SHIBAYAMApending
ABHD6 ANTAGONISTA61P 25/00, A61K 31/501, A61K 31/5025, C07D 409/14, A61P 43/00, A61P 25/02, A61P 25/22, A61P 25/24, A61P 29/00, A61K 31/167, A61K 45/06, C07D 417/14, C07D 495/04, C07D 513/04, C07D 519/00Filed as ONO PHARMACEUTICAL CO., LTD.2025-03-20Atsushi YOSHIDApending
COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOFA61K 9/0019, C07D 403/12, C07D 413/14, A61P 25/28, A61P 35/00, A61K 9/2054, A61K 31/4155, A61K 31/4178, A61K 31/422, C07D 403/14Filed as ONO PHARMACEUTICAL CO., LTD.2025-02-28Akito KAKUUCHIpending
BENZENE DERIVATIVEA61K 45/06, C07C 311/21, C07D 213/71, C07C2601/08, A61P 25/00, A61K 31/18, A61K 31/192, A61K 31/196, A61K 31/425, C07B2200/07, C07C 59/64, C07C 59/68, C07C 311/14, C07D 209/08, C07D 209/44, C07D 213/76, C07D 215/58, C07D 217/08, C07D 277/24, C07D 295/185, C07D 305/06, C07D 307/14, C07D 307/82, C07D 309/04, C07D 309/08, C07D 333/34, C07D 333/62, C12N 5/0622, C12N2501/999Filed as ONO PHARMACEUTICAL CO., LTD.2025-02-20Shoji NOJIMApending
BISPECIFIC ANTIBODYA61K 39/395, A61K 45/06, C07K 16/00, C07K 16/44, A61P 35/00, A61K2039/505, C07K 16/28, C07K 16/46, C07K2317/24, C07K2317/31, C07K2317/34, C07K2317/526, C07K2317/565, C07K2317/622, C07K2317/76, C07K2317/92Filed as ONO PHARMACEUTICAL CO., LTD.2025-02-13Shiro SHIBAYAMApending
BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSESA61K 31/335, A61K 9/0048, A61K 31/4427, A61K 31/558, C07D 313/06, C07D 401/06, C07D 405/06, C07D 407/12, C07D 417/04Filed as ONO PHARMACEUTICAL CO., LTD.2024-12-11Tohru KAMBEpending
PURINONE DERIVATIVEC07D 473/34, A61P 43/00, A61P 37/06, A61P 29/00, A61P 35/00, A61K 31/522Filed as ONO PHARMACEUTICAL CO., LTD.2024-10-30Shingo YAMAMOTOpending
COMPOSITION FOR OPHTHALMIC USE CONTAINING SEPETAPROSTA61P 27/02, A61K 31/558, A61P 27/06, A61L2103/10, A61F 9/0008, A61J 1/067, A61K 9/0048, A61K 9/08, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/183, A61K 47/186, A61K 47/26, A61L 2/022Filed as ONO PHARMACEUTICAL CO., LTD.2024-10-21Yoko ENDOpending
DP ANTAGONISTA61K 9/2054, C07D 309/06, C07C2601/02, C07C2601/14, C07C2602/08, A61P 25/20, A61P 43/00, A61P 25/18, A61P 25/00, A61K 31/196, A61K 31/216, A61K 31/351, C07C 233/81, C07C 235/56, C07C 235/64, C07C 235/78, C07C 327/48Filed as ONO PHARMACEUTICAL CO., LTD.2024-10-14Masaki ASADApending
STING AGONISTIC COMPOUNDC07D 498/04, C07F 9/6561, A61P 31/00, A61P 35/02, A61P 35/00, A61K 31/437, A61K 31/661, A61K 45/06, C07D 513/04, C07F 9/062Filed as ONO PHARMACEUTICAL CO., LTD.2024-10-10Ryosuke HANADApending
CHIMERIC ANTIGEN RECEPTOR FOR TUMOR TARGETINGC07K 14/7051, C07K 16/32, A61P 35/00, A61K2239/13, A61K2239/10, A61K2239/21, A61K2239/49, A61K 40/4205, A61K 40/31, A61K 40/11, A61K 35/17, A61K2039/5156, C07K 14/70521, C07K2317/24, C07K2317/565, C07K2317/622, C07K2319/02, C07K2319/03, C07K2319/33Filed as ONO PHARMACEUTICAL CO., LTD.2024-10-07Bahram VALAMEHRpending
COMPOUNDS HAVING S1P5 RECEPTOR AGONISTIC ACTIVITYC07D 205/04, C07D 403/04, Y02P 20/55, A61P 37/00, A61P 21/00, A61P 25/28, A61P 31/00, A61P 37/06, A61P 25/18, A61P 25/00, A61P 25/16, A61P 35/00, A61K 31/397, A61K 31/40, C07C 49/252, C07C 49/577, C07D 207/16Filed as ONO PHARMACEUTICAL CO., LTD.2024-06-14Toshihide WATANABEpending
BISPECIFIC ANTIBODYA61P 37/02, C07K 16/2818, A61P 21/00, A61P 17/00, A61P 19/02, A61P 37/08, A61K 38/00, A61K 45/06, A61K2039/505, C07K 16/2809, C07K 16/468, C07K2317/31, C07K2317/565, C07K2317/76, C07K2317/92Filed as ONO PHARMACEUTICAL CO., LTD.2024-04-30Shiro SHIBAYAMApending
SUBSTITUTED CYCLOPENTA[c]PYRROLES AS ABHD6 ANTAGONISTSA61K 31/136, C07D 409/14, C07D 495/14, A61P 37/00, A61P 43/00, A61P 3/00, A61P 9/06, A61P 25/04, A61P 21/02, A61P 25/24, A61P 25/00, A61P 25/08, A61P 29/00, A61P 19/10, A61P 25/06, A61P 35/00, A61K 9/20, A61K 31/4439, A61K 31/501, A61K 45/00, A61K 45/06, C07D 403/12, C07D 405/14, C07D 417/14, C07D 487/04, C07D 495/04, C07D 513/04Filed as ONO PHARMACEUTICAL CO., LTD.2024-04-08Atsushi Yoshida12600730
PROCESS FOR MAKING AN EP4 ANTAGONISTC07D 311/58, C07D 311/96Filed as ONO PHARMACEUTICAL CO., LTD.2024-02-01Ryoichi ARIHARApending

Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.

More on OPHLY

Company overviewEverything on OPHLY in one place, with the price.Who owns itEvery manager reporting a position in OPHLY.LobbyingWhat OPHLY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on OPHLY's account, and who they worked for.

Related datasets

Corporate LobbyingWhat companies spend lobbying Congress, and on what.Lobbying FirmsThe shops companies hire, and who else they represent.Government ContractsWhat federal agencies pay those same companies.Revolving DoorFormer staff now lobbying, and who they worked for.